Related Experiment Videos
Agranulocytosis associated with etodolac
R L Cramer1, V C Aboko-Cole, R J Gualtieri
1Department of Pharmacy, Huntsville Hospital, AL 35801.
The Annals of Pharmacotherapy
|April 1, 1994
Summary
This case report details a probable instance of etodolac-induced agranulocytosis, a rare side effect of nonsteroidal anti-inflammatory drugs (NSAIDs). Clinicians should monitor for this serious adverse event associated with etodolac use.
Area of Science:
- Pharmacology
- Hematology
- Clinical Medicine
Background:
- Agranulocytosis is a rare but serious adverse effect associated with some nonsteroidal anti-inflammatory drugs (NSAIDs).
- Literature reports linking etodolac to agranulocytosis are notably absent.